JPWO2021134045A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021134045A5 JPWO2021134045A5 JP2022538731A JP2022538731A JPWO2021134045A5 JP WO2021134045 A5 JPWO2021134045 A5 JP WO2021134045A5 JP 2022538731 A JP2022538731 A JP 2022538731A JP 2022538731 A JP2022538731 A JP 2022538731A JP WO2021134045 A5 JPWO2021134045 A5 JP WO2021134045A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962953860P | 2019-12-26 | 2019-12-26 | |
| US62/953,860 | 2019-12-26 | ||
| PCT/US2020/067074 WO2021134045A1 (en) | 2019-12-26 | 2020-12-26 | Methods and compositions for inhibition of dihydroorotate dehydrogenase in combination with an anti-cd38 therapeutic agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023508938A JP2023508938A (ja) | 2023-03-06 |
| JPWO2021134045A5 true JPWO2021134045A5 (zh) | 2024-01-25 |
Family
ID=76575158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022538731A Pending JP2023508938A (ja) | 2019-12-26 | 2020-12-26 | 抗ｃｄ３８治療剤と組み合わせたジヒドロオロト酸デヒドロゲナーゼの阻害のための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230303710A1 (zh) |
| EP (1) | EP4081219A4 (zh) |
| JP (1) | JP2023508938A (zh) |
| KR (1) | KR20220133198A (zh) |
| CN (1) | CN115335052A (zh) |
| AU (1) | AU2020412805A1 (zh) |
| CA (1) | CA3165475A1 (zh) |
| WO (1) | WO2021134045A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023091793A1 (en) * | 2021-11-22 | 2023-05-25 | Ohio State Innovation Foundation | Methods and compositions for targeting alternative metabolism along with flt3 inhibitor-mediated antileukemic actions |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7405237B2 (en) * | 2004-07-28 | 2008-07-29 | Celgene Corporation | Isoindoline compounds and methods of their use |
| CN112480257A (zh) * | 2005-03-23 | 2021-03-12 | 根马布股份公司 | 用于治疗多发性骨髓瘤的cd38抗体 |
| NO2582728T3 (zh) * | 2010-06-15 | 2018-01-20 | ||
| CA2996632C (en) * | 2015-09-01 | 2023-10-17 | Bayer Pharma Aktiengesellschaft | Compounds and methods useful for treating or preventing hematological cancers |
| JP6961879B2 (ja) * | 2015-12-30 | 2021-11-05 | レ ラボラトワール セルヴィエ ソシエテ・パール・アクシオンス・サンプリフィエ | 変異体イソクエン酸デヒドロゲナーゼを包含する腫瘍の処置 |
| US10478497B2 (en) * | 2016-07-20 | 2019-11-19 | Hybrigenics S.A. | Combinations of inecalcitol with an anti-CD38 agent and their uses for treating cancer |
| JP7370958B2 (ja) * | 2017-07-31 | 2023-10-30 | アクティニウム ファーマシューティカルズ インコーポレイテッド | 血液悪性腫瘍の治療 |
| JP7373170B2 (ja) * | 2018-06-22 | 2023-11-02 | オハイオ ステート イノベーション ファウンデーション | ジヒドロオロト酸デヒドロゲナーゼ阻害のための方法及び組成物 |
| WO2021134042A1 (en) * | 2019-12-26 | 2021-07-01 | Ohio State Innovation Foundation | Methods and compositions for inhibition of dihydroorotate dehydrogenase |
| WO2021133831A1 (en) * | 2019-12-26 | 2021-07-01 | Ohio State Innovation Foundation | Compositions for use for the inhibition of dihydroorotate dehydrogenase |
| US20230089524A1 (en) * | 2019-12-26 | 2023-03-23 | Ohio State Innovation Foundation | Compositions for use in the inhibition of dihydroorotate dehydrogenase |
-
2020
- 2020-12-26 AU AU2020412805A patent/AU2020412805A1/en active Pending
- 2020-12-26 WO PCT/US2020/067074 patent/WO2021134045A1/en unknown
- 2020-12-26 CN CN202080095284.0A patent/CN115335052A/zh active Pending
- 2020-12-26 EP EP20905006.1A patent/EP4081219A4/en active Pending
- 2020-12-26 US US17/789,187 patent/US20230303710A1/en active Pending
- 2020-12-26 CA CA3165475A patent/CA3165475A1/en active Pending
- 2020-12-26 KR KR1020227025804A patent/KR20220133198A/ko unknown
- 2020-12-26 JP JP2022538731A patent/JP2023508938A/ja active Pending